DonEEslinMD

Clinical Trials

• Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01

  Completed

  Phase 3

• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14

  Completed

  Phase 2

• Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Start of enrollment: 2010 Jun 01

  Terminated

  Phase 3

• Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18

  Completed

  Phase 1

• Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Start of enrollment: 2011 Dec 01

  Terminated

  Phase 1, Phase 2

• Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Start of enrollment: 2011 Dec 01

  Terminated

  Phase 1, Phase 2

• Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01

  Active, not recruiting

  Phase 2

• Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04

  Completed

  Not Applicable

• Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma Start of enrollment: 2014 Jun 06

  Completed

  Phase 1, Phase 2

• Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08

  Completed

  Not Applicable

• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01

  Recruiting

  Phase 2

• Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01

  Recruiting

  Phase 2

• Join now to see all